BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1150352)

  • 1. The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians.
    Betuel H; Camoun M; Colombani J; Day NE; Ellouz R; de-Thé G
    Int J Cancer; 1975 Aug; 16(2):249-54. PubMed ID: 1150352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC.
    Simons MJ; Wee GB; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
    IARC Sci Publ (1971); 1975; (11 Pt 2):249-58. PubMed ID: 191368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma.
    Dardari R; Khyatti M; Jouhadi H; Benider A; Ettayebi H; Kahlain A; Mansouri A; El Gueddari B; Benslimane A
    Int J Cancer; 2001 Apr; 92(2):294-7. PubMed ID: 11291059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histocompatibility leukocyte antigen patterns and nasopharyngeal carcinoma.
    Simons MJ; Day NE
    Natl Cancer Inst Monogr; 1977 Dec; 47():143-6. PubMed ID: 613232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia.
    Mokni-Baizig N; Ayed K; Ayed FB; Ayed S; Sassi F; Ladgham A; Bel Hadj O; El May A
    Oncology; 2001; 61(1):55-8. PubMed ID: 11474249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians.
    Hassen E; Ghedira R; Ghandri N; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L
    DNA Cell Biol; 2011 Aug; 30(8):603-9. PubMed ID: 21332388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2).
    Simons MJ; Wee GB; Goh EH; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
    J Natl Cancer Inst; 1976 Nov; 57(5):977-80. PubMed ID: 1003552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2) associated with an increased risk in Chinese for nasopharyngeal carcinoma.
    Simons MJ; Wee GB; Singh D; Dharmalingham S; Yong NK; Chau JC; Ho JH; Day NE; De-Thé G
    Natl Cancer Inst Monogr; 1977 Dec; 47():147-51. PubMed ID: 613233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma.
    Simons MJ; Wee GB; Chan SH; Shanmugaratnam K
    Lancet; 1975 Jan; 1(7899):142-3. PubMed ID: 46054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in nasopharyngeal cancer incidence among specific Chinese communities (dialect groups) in Singapore.
    Shanmugaratnam K
    IARC Sci Publ (1971); 1978; (20):191-8. PubMed ID: 730189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome.
    Ghandri N; Gabbouj S; Farhat K; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L; Hassen E
    Hum Immunol; 2011 Feb; 72(2):150-8. PubMed ID: 20969909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A*26-A*30 and HLA-DRB1*10 could be predictors of nasopharyngeal carcinoma risk in high-risk Tunisian families.
    Mokni-Baizig N; Gorgi Y; Elghourabi M; Makhlouf M; Boussen H; Gritli S; Elmay M; Gamoudi A; Elmay A
    J Oral Sci; 2017; 59(2):289-296. PubMed ID: 28637989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups.
    Simons MJ; Wee GB; Day NE; Morris PJ; Shanmugaratnam K; De-Thé GB
    Int J Cancer; 1974 Jan; 13(1):122-34. PubMed ID: 4131857
    [No Abstract]   [Full Text] [Related]  

  • 14. Nasopharyngeal carcinoma and histocompatibility antigens.
    Simons MJ; Chan SH; Wee GB; Shanmugaratnam K; Goh EH; Ho JH; Chau JC; Darmalingam S; Prasad U; Betuel H; Day NE; de-The G
    IARC Sci Publ (1971); 1978; (20):271-82. PubMed ID: 730194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese.
    Lu CC; Chen JC; Jin YT; Yang HB; Chan SH; Tsai ST
    Int J Cancer; 2003 Mar; 103(6):745-51. PubMed ID: 12516093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis.
    Goldsmith DB; West TM; Morton R
    Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):61-7. PubMed ID: 11903375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic components in susceptibility to nasopharyngeal carcinoma.
    Kirk RL; Blake NM; Serjeantson S; Simons MJ; Chan SH
    IARC Sci Publ (1971); 1978; (20):283-97. PubMed ID: 730195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and nasopharyngeal carcinoma in Chinese--a further study.
    Chan SH; Day NE; Kunaratnam N; Chia KB; Simons MJ
    Int J Cancer; 1983 Aug; 32(2):171-6. PubMed ID: 6874140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal carcinoma incidence in North Tunisia: negative trends in adults but not adolescents, 1994-2006.
    Wided BA; Hamouda B; Hamadi H; Mansour BA
    Asian Pac J Cancer Prev; 2015; 16(7):2653-7. PubMed ID: 25854341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E polymorphism in patients with nasopharyngeal carcinoma.
    Hirankarn N; Kimkong I; Mutirangura A
    Tissue Antigens; 2004 Nov; 64(5):588-92. PubMed ID: 15496202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.